- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/22 - Ribonucleases
Patent holdings for IPC class C12N 9/22
Total number of patents in this class: 14573
10-year publication summary
|
488
|
725
|
919
|
1171
|
1269
|
1413
|
1698
|
1958
|
1770
|
951
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20745 |
604 |
| The Broad Institute, Inc. | 1977 |
554 |
| Massachusetts Institute of Technology | 10251 |
486 |
| President and Fellows of Harvard College | 6094 |
484 |
| Pairwise Plants Services, Inc. | 293 |
177 |
| The General Hospital Corporation | 4870 |
170 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
160 |
| Sangamo Therapeutics, Inc. | 383 |
153 |
| Beam Therapeutics Inc. | 289 |
145 |
| Cellectis | 415 |
143 |
| Editas Medicine, Inc. | 251 |
143 |
| Arbor Biotechnologies Inc. | 169 |
142 |
| Pioneer Hi-Bred International, Inc. | 7015 |
140 |
| CRISPR Therapeutics AG | 367 |
138 |
| Regeneron Pharmaceuticals, Inc. | 4701 |
136 |
| Duke University | 3183 |
126 |
| Precision Biosciences, Inc. | 209 |
125 |
| Novozymes A/S | 3384 |
123 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 270 |
123 |
| EmendoBio Inc. | 156 |
119 |
| Other owners | 10182 |